# EDGAR Filing Document

**Accession Number:** 0002010788
**File Stem:** 0001493152-25-027949
**Filing Date:** 2025-12
**Character Count:** 29503
**Document Hash:** 034a1c92eae443694c0cfddf72ce6e64
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-027949.hdr.sgml**: 20251216

**ACCESSION NUMBER**: 0001493152-25-027949

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20251216

**DATE AS OF CHANGE**: 20251216

**EFFECTIVENESS DATE**: 20251216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EXOZYMES INC.
- **CENTRAL INDEX KEY:** 0002010788
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 834550057
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292165
- **FILM NUMBER:** 251574804

**BUSINESS ADDRESS:**
- **STREET 1:** 750 ROYAL OAKS DR
- **CITY:** MONROVIA
- **STATE:** CA
- **ZIP:** 91016
- **BUSINESS PHONE:** (626) - 415 - 1488

**MAIL ADDRESS:**
- **STREET 1:** 750 ROYAL OAKS DR
- **CITY:** MONROVIA
- **STATE:** CA
- **ZIP:** 91016

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Invizyne Technologies Inc
- **DATE OF NAME CHANGE:** 20240205

As filed with the Securities and Exchange Commission on December 15, 2025

Registration No. 333-____

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form S-8**

REGISTRATION STATEMENT

Under

THE SECURITIES ACT OF 1933

**EXOZYMES INC.**

(Exact Name of Registrant as Specified in Its Charter)

---

| | |
|:---|:---|
| **Nevada** | **83-4550057** |
| State or Other Jurisdiction of<br> Incorporation or Organization | (I.R.S. Employer<br> Identification Number) |

---

**750 Royal Oaks Drive, Suite 106**

**Monrovia, CA 91016**

(Address of Principal Executive Offices)

**2025 Performance Equity Plan**

(Full Title of the Plan)

**Exozymes Inc.**

**Fouad Nawaz, Vice President, Finance**

**750 Royal Oaks Drive, Suite 106**

**Monrovia, CA 91016**

**(626) 415-1488**

(Name, Address and Telephone Number, Including Area Code, of Agent for Service)

with a copy to:

**Andrew Hudders, Esq.**

**Golenbock Eiseman Assor Bell & Peskoe LLP**

**711 Third Avenue, Floor 17**

**New York, New York 10017**

**Telephone: (212) 907-7349**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☒

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☒

In accordance with the provisions of Rule 462 promulgated under the Securities Act, this registration statement will become effective upon filing with the Securities and Exchange Commission.

**PART I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS**

**Item 1. Plan Information.**\*

**Item 2. Registrant Information and Employee Plan Annual Information.** \*

\* The documents containing the information specified in this Part I will be sent or given to the participants as specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the "Securities Act"). Such documents need not be filed with the Securities and Exchange Commission (the "SEC") either as part of this registration statement or as prospectuses or prospectus supplements pursuant to Rule 424 of the Securities Act. These documents and the documents incorporated by reference in this registration statement pursuant to Item 3 of Part II of this registration statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference.**

The following documents previously or concurrently filed by the Registrant with the Securities and Exchange Commission ("SEC") are hereby incorporated by reference in this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;1. The
 Registrant's Annual Report on [Form 10-K](https://www.sec.gov/Archives/edgar/data/2010788/000164117225001744/form10-k.htm) , for the fiscal year ended December 31, 2024, filed March 31, 2025;

2. The
 Registrant's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, filed [May 12, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225009636/form10-q.htm) , June 30, 2025, filed [August 12, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225023184/form10-q.htm) and September 30, 2025, filed [November 13, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000149315225022289/form10-q.htm) ;

3. The
 Registrant's Current Reports on Form 8-K filed with the SEC on [February 11, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000149315225005961/form8-k.htm) , [February 21, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000149315225007884/form8-k.htm) , [April 2, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225002394/form8-k.htm) , [April 2, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225002396/form8-k.htm) , [June 20, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225015782/form8-k.htm) , [June 26, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225016681/form8-k.htm) , [July 8, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225018053/form8-k.htm) , [July 28, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000164117225021084/form8-k.htm) , and [October 3, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000149315225016831/form8-k.htm) ;

4. The
 description of the Registrant's common stock contained in a registration statement on [Form 8-A12B](https://www.sec.gov/Archives/edgar/data/2010788/000149315224029933/form8a-12b.htm) filed with the Securities
 and Exchange Commission on August 1, 2024, pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
 including any amendment or report filed for the purpose of updating such description, including the [Exhibit 4.3](https://www.sec.gov/Archives/edgar/data/2010788/000164117225001744/ex4-3.htm) to the Registrant's
 Annual Report on Form 10-K, for the fiscal year ended December 31, 2024;

5. The
 Registrant's Proxy Statement as filed [June 20, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm) , as amended by Amendment No. 1, filed on [June 23, 2025](https://www.sec.gov/Archives/edgar/data/2010788/000114036125023395/ny20050076x2_defr14a.htm) ; and

6. All
 other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year for which audited financial
 statements of the Registrant have been filed.

All documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the respective dates of filing of such documents.

Any statement contained in a document incorporated or deemed to be incorporated by reference in this Registration Statement shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in this Registration Statement, or in any other subsequently filed document that also is or is deemed to be incorporated by reference in this Registration Statement, modifies or supersedes such prior statement. Any statement contained in this Registration Statement shall be deemed to be modified or superseded to the extent that a statement contained in a subsequently filed document that is or is deemed to be incorporated by reference in this Registration Statement modifies or supersedes such prior statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 4. Description of Securities.**

Not applicable.

**Item 5. Interests of Named Experts and Counsel.**

Not applicable.

**Item 6. Indemnification of Directors and Officers.**

We are a Nevada corporation. The Nevada Revised Statutes ("NRS") provides that the articles of incorporation of a Nevada corporation may contain a provision eliminating or limiting the personal liability of a director to the corporation or its shareholders for monetary damages for breach of fiduciary duty as a director, except that any such provision may not eliminate or limit the liability of a director (i) for any breach of the director's duty of loyalty to the corporation or its shareholders, (ii) acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) acts specified in Section 78 (concerning unlawful distributions), or (iv) any transaction from which a director directly or indirectly derived an improper personal benefit.

The NRS provides that a Nevada corporation must indemnify a person who was wholly successful, on the merits or otherwise, in defense of any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative and whether formal or informal, in which he or she was a party because the person is or was a director, against reasonable expenses incurred by him or her in connection with the proceeding, unless such indemnity is limited by the corporation's articles of incorporation.

The NRS provides that a Nevada corporation may indemnify a person made a party to a proceeding because the person is or was a director against any obligation incurred with respect to a proceeding to pay a judgment, settlement, penalty, fine (including an excise tax assessed with respect to an employee benefit plan) or reasonable expenses incurred in the proceeding if the person conducted himself or herself in good faith and the person reasonably believed, in the case of conduct in an official capacity with the corporation, that the person's conduct was in the corporation's best interests and, in all other cases, his or her conduct was at least not opposed to the corporation's best interests and, with respect to any criminal proceedings, the person had no reasonable cause to believe that his or her conduct was unlawful. A corporation may not indemnify a director in connection with any proceeding by or in the right of the corporation in which the director was adjudged liable to the corporation or, in connection with any other proceeding charging that the director derived an improper personal benefit, whether or not involving actions in an official capacity, in which proceeding the director was judged liable on the basis that he or she derived an improper personal benefit. Any indemnification permitted in connection with a proceeding by or in the right of the corporation is limited to reasonable expenses incurred in connection with such proceeding.

Under the NRS, unless otherwise provided in the articles of incorporation, a Nevada corporation may indemnify an officer, employee, fiduciary, or agent of the corporation to the same extent as a director and may indemnify such a person who is not a director to a greater extent, if not inconsistent with public policy and if provided for by its bylaws, general or specific action of its board of directors or shareholders, or contract.

Our articles of incorporation provide that we will indemnify to the fullest extent permitted by Nevada law any person made or threatened to be made a party to any threatened, pending or completed action or proceeding, whether civil, criminal, administrative or investigative (whether or not by or in the right of the Company) by reason of the fact that he or she is or was a director of the Company or is or was serving as a director, officer, employee or agent of another entity at the request of the Company or any predecessor of the Company against judgments, fines, penalties, excise taxes, amounts paid in settlement and costs, charges and expenses (including attorneys' fees and disbursements) that he or she incurs in connection with such action or proceeding.

Our articles of incorporation also provide that to the fullest extent permitted by NRS 78, a director or officer of the Company will not be personally liable to the company or its stockholders for damages for breach of fiduciary duty as a director or officer, provided that the foregoing will not eliminate or limit the liability of a director or officer for: (a) acts or omissions which involve intentional misconduct, fraud or a knowing violation of law; or (b) the payment of distributions in violation of NRS 78.300.

The registrant has directors' and officers' liability insurance for its directors and officers.

The Company also enters into indemnification agreements with each of the persons serving on the board of directors and executive officers. The indemnification agreements provide for indemnification against expenses, judgments, fines and penalties actually and reasonably incurred by an indemnitee in connection with threatened, pending or completed actions, suits or other proceedings, subject to certain limitations. The indemnification agreements also provide for the advancement of expenses in connection with a proceeding prior to a final, non-appealable judgment or other adjudication, provided that the indemnitee provides an undertaking to repay to us any amounts advanced if the indemnitee is ultimately found not to be entitled to indemnification by us. The indemnification agreement sets forth procedures for making and responding to a request for indemnification or advancement of expenses, as well as dispute resolution procedures that apply to any dispute between us and an indemnitee arising under the indemnification agreements.

**Item 8. Exhibits.**

See the attached Exhibit Index, which is incorporated herein by reference.

**Item 9. Undertakings.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The undersigned Registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To
 include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) To
 reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
 post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
 forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
 the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
 of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission
 pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum
 aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement;
 and

(iii) To
 include any material information with respect to the plan of distribution not previously disclosed in the registration statement
 or any material change to such information in the registration statement;

*provided, however*, that paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Securities and Exchange Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial *bona fide* offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial *bona fide* offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described in Item 6 above, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Monrovia, State of California, on December 15, 2025.

---

| | |
|:---|:---|
| EXOZYMES INC. | EXOZYMES INC. |
| By: | */s/ Michael Heltzen* |
|  | Michael Heltzen |
|  | Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears below constitutes and appoints Michael Heltzen and Fouad Nawaz and each of them, his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this registration statement, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Michael Heltzen* | Chief Executive Officer and President | December 15, 2025 |
| Michael Heltzen | (Principal Executive Officer) |  |
| */s/ Fouad Nawaz* | Vice President, Finance | December 15, 2025 |
| Fouad Nawaz | (Principal Financial and Accounting Officer) |  |
| */s/ Christopher Marlett* | Chairman of the Board and Director | December 15, 2025 |
| Christopher Marlett |  |  |
| */s/ Anthony DiGiandomenico* | Director | December 15, 2025 |
| Anthony DiGiandomenico |  |  |
| */s/ James U. Bowie* | Director | December 15, 2025 |
| James U. Bowie |  |  |
| */s/ Lon E. Bell* | Director | December 15, 2025 |
| Lon E. Bell |  |  |
| */s/ James J. Lalonde* | Director | December 15, 2025 |
| James J. Lalonde |  |  |
| */s/ Edgardo Rayo* | Director | December 15, 2025 |
| Edgardo Rayo |  |  |

---

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 4.1\*\* | [EXoZymes Inc. 2025 Performance Equity Plan (incorporated herein by reference from Schedule A of the Proxy Statement for the 2025 Annual Meeting of the Registrant, filed with the SEC on June 20, 2025)](https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm#tSFOPP) |
| 5.1 \* | [Opinion of Golenbock Eiseman Assor Bell & Peskoe LLP](ex5-1.htm) |
| 23.1 \* | [Consent of RBSM LLP](ex23-1.htm) |
| 23.2 \* | [Consent of Golenbock Eiseman Assor Bell & Peskoe LLP (included in Exhibit 5.1)](ex5-1.htm) |
| 24.1 \* | [Power of Attorney (included on the signature page of this registration statement)](#ak_001) |
| 107 \* | [Filing Fee Table](ex107.htm) |

---

\* Filed herewith

\*\* Previously filed

## Exhibit 5.1

**Exhibit 5.1**

**Golenbock Eiseman Assor Bell & Peskoe LLP**

**711 Third Avenue**

**New York, New York 10017**

**Attorneys at Law**

**Tel. 212-907-7300 / Fax 212-754-0330 / www.golenbock.comn**

December 15, 2025

eXoZymes Inc.

750 Royal Oaks Drive, Suite 106

Monrovia, CA 91016

RE: 2025 Performance Equity Plan of eXoZymes Inc. – Registration Statement on Form S-8

Ladies and Gentlemen:

We have acted as counsel to eXoZymes Inc., a Nevada corporation (the "Company"), in connection with a Registration Statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended (the "Act"), relating to the issuance by the Company from time to time of up to 1,250,000 shares of common stock $0.000001 par value (the "Shares"), pursuant to the Company's 2025 Performance Equity Plan (the "Plan").

We have examined such documents and considered such legal matters as we have deemed necessary and relevant as the basis for the opinion set forth below. With respect to such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as reproduced or certified copies, and the authenticity of the originals of those latter documents. We have also assumed that in granting future awards under the Plan, the Board of Directors of the Company or the appropriate committee thereunder will exercise its discretion in establishing the terms of such awards within the permissible limits of the law of the State of Nevada, the Certificate of Incorporation, as amended, and by laws, each as then in effect.

Based upon the foregoing, it is our opinion that the Shares to be issued by the Company under the Plan, when sold in accordance with the terms of the Plan and the individual instruments or agreements governing their issuance, will be legally issued, fully paid and non-assessable, although they may be subject to contractual restrictions established by the Plan or the individual instrument or agreement.

In giving this opinion, we have assumed that all certificates or book entry evidence for the Shares, prior to their issuance, will be duly executed or created on behalf of the Company by the Company's transfer agent and the shares and their issuance appropriately registered by the Company's registrar, if necessary, and will conform, except as to name, address and denominations, to specimens which we have examined.

We express no opinion as to the applicability or effect of any laws, orders or judgments of any state or other jurisdiction other than federal securities laws and the Nevada Revised Statutes as they pertain to corporations of the State of Nevada. Further, this opinion speaks as of the date hereof and is based solely upon existing laws, rules and regulations, and we undertake no obligation to advise you of any changes that may be brought to our attention after the date hereof. This opinion is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company or the Shares.

This opinion is issued to you solely for use in connection with the Registration Statement and is not to be quoted or otherwise referred to in any financial statements of the Company or any other document, nor is it to be filed with or furnished to any government agency or other person, without our prior written consent.

We hereby consent to the use of this opinion as an exhibit to the Registration Statement, to the use of our name as your counsel and to all references made to us in the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act, or the rules and regulations promulgated thereunder.

---

| |
|:---|
| Very Truly Yours, |
| /S/ Golenbock Eiseman Assor Bell & Peskoe LLP |

---

## Exhibit 23.1

**Exhibit 23.1**

---

| | |
|:---|:---|
| ![](ex23-1_001.jpg) | ***Nevada Office:***<br> ****<br> 770 East Warm Springs Road<br> Suite 225<br> Las Vegas, Nevada 89119<br> 702.413.6000<br>*<u>www.rbsmllp.com</u>*  |

---

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of our report dated March 31, 2025 on the consolidated financial statements of eXoZymes Inc. and its subsidiary, appearing in the Annual Report on Form 10-K of eXoZymes Inc. for the year ended December 31, 2024. Our report includes an explanatory paragraph expressing substantial doubt regarding the Company's ability to continue as a going concern.

*/s/ RBSM LLP*

Las Vegas, NV

December 11, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'?

**Exhibit 107**

**Calculation of Filing Fee Table**

**FORM S-8**

(Form Type)

**EXoZymes Inc.**

(Exact Name of Registrant as Specified in its Charter)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security<br> Type** | **Security <br> Class<br> Title** | **Fee<br> Calculation<br> Rule** | **Amount<br> Registered<sup>(1)</sup>** | **Amount<br> Registered<sup>(1)</sup>** | **Proposed<br> Maximum<br> Offering<br> Price<br> Per<br> Share<sup>(2)</sup>** | **Maximum<br> Aggregate<br> Offering<br> Price** | **Fee <br> Rate** | **Amount of<br> Registration<br> Fee** |
| Equity | Common Stock, $.000001, par value per share | Other |  | 1250000 | $14.25 | $17812500.00 | 0.0001381 | $2459.91 |
| **Total Offering Amounts** |  |  |  |  |  | $17812500.00 |  | $2459.91 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  |  |  |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  |  | $2459.91 |

---

(1) Pursuant
 to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall
 also cover any additional shares of common stock of the registrant that become issuable under the 2025 Performance Equity Plan by
 reason of any stock dividend, stock split, recapitalization or similar transaction effected without the Registrant's receipt
 of consideration which would increase the number of outstanding shares of common stock of the registrant.

(2) Estimated
 solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under
 the Securities Act. The Proposed Maximum Offering Price Per Share is based on the average of the high and the low price of a share
 of common stock of the registrant as reported on the Nasdaq Capital Market on December 9, 2025.